Karl Landsteiner's Lifelong Search Through Human Blood

Today, asking someone their blood type sounds completely normal.

A positive.

B negative.

O negative.

AB positive.

We put blood types on medical records. Hospitals test them before transfusions. Blood banks separate donations by type. Pregnant women are tested for ABO and Rh status as part of prenatal care.

But just over a century ago, doctors did not understand that human beings had fundamentally different blood groups.

They knew blood was essential to life.

They knew a person who had lost too much blood might die.

And physicians had already experimented with transferring blood from one person to another.

Sometimes it worked.

Sometimes the patient became violently ill.

Sometimes the patient died.

Nobody fully understood why.

Then one scientist began mixing blood samples in a laboratory in Vienna.

His name was Karl Landsteiner.

What he discovered would change medicine forever.

Before Blood Types

The idea of replacing lost blood is much older than modern medicine.

Physicians had experimented with transfusion for centuries, including early attempts involving animal blood.

By the nineteenth century, doctors were increasingly experimenting with human to human transfusion.

But there was a frightening problem.

The results were unpredictable.

One transfusion might appear to help.

Another could produce a devastating reaction.

Without knowing that human blood could be divided into different groups, doctors had no reliable way to determine whether a donor's blood was compatible with the person receiving it.

The missing piece was sitting right in front of them.

Not all human blood behaves the same way.

Karl Landsteiner

Karl Landsteiner was born in Vienna on June 14, 1868.

He studied medicine at the University of Vienna and graduated in 1891. But his interests stretched beyond simply practicing medicine.

He was fascinated by chemistry.

He was fascinated by immunity.

He was fascinated by antibodies.

Most importantly, he seemed determined to understand why human blood behaved the way it did.

That curiosity eventually led him to an experiment that looks remarkably simple today.

Landsteiner separated the red blood cells and serum from blood samples taken from himself and his colleagues.

Then he began mixing them in different combinations.

Something strange happened.

Some combinations mixed without a dramatic reaction.

Others caused the red blood cells to clump together.

This clumping is called agglutination.

Landsteiner realized that the reaction wasn't random.

There was a pattern.

Human Blood Was Not All the Same

That observation led Landsteiner to one of the most important discoveries in medical history.

Human beings could be divided into different blood groups.

Landsteiner initially identified three groups that became A, B and O.

The fourth major ABO group, AB, was identified shortly afterward by other researchers.

For the first time, science had an explanation for why blood from one person might be compatible with another person's blood while a different combination could produce a dangerous reaction.

The problem wasn't simply “good blood” or “bad blood.”

The problem was compatibility.

Modern research now describes the ABO system in terms of antigens on red blood cells and naturally occurring antibodies in plasma.

A person with type A blood carries A antigen on the red blood cells and generally has antibodies against B.

A person with type B carries B antigen and generally has antibodies against A.

A person with AB expresses both A and B antigens.

A person with O expresses neither A nor B antigen on the red blood cells.

That knowledge sounds basic today.

At the beginning of the twentieth century, it was revolutionary.

Learn more about the ABO blood group system from the National Library of Medicine

Why Incompatible Blood Can Be Dangerous

Landsteiner's experiments helped explain something physicians had witnessed without understanding.

If incompatible red blood cells enter a person's circulation, antibodies can recognize antigens on those cells.

The resulting immune reaction can cause red blood cells to clump and be destroyed.

A transfusion intended to save someone's life could therefore become dangerous.

Landsteiner had found a way to predict compatibility before the blood ever entered the patient's body.

That helped lay the foundation for modern transfusion medicine.

Today, blood banks perform far more sophisticated compatibility testing than Landsteiner could have imagined.

But the basic principle remains.

Before blood is given, we want to know whether the donor's red blood cells are compatible with the recipient.

Read the National Library of Medicine's history of human blood groups

A Discovery That Changed Medicine

Landsteiner published his blood group findings in the early twentieth century.

The implications were enormous.

Doctors could begin moving away from transfusion as a dangerous gamble and toward a scientific system based on compatibility.

Other discoveries followed.

Researchers learned more about antibodies.

They learned more about antigens.

They learned how blood groups are inherited.

They developed methods for blood typing and crossmatching.

Blood banks became possible.

Emergency transfusion medicine became safer.

Surgery became safer.

Trauma medicine became safer.

The ability to store and match donated blood eventually became one of the foundations of modern healthcare.

Landsteiner had discovered something invisible to the naked eye that affected almost everyone on Earth.

Your Blood Type Is Inherited

The story became even more interesting when researchers began understanding inheritance.

Your ABO blood type isn't randomly assigned when you're born.

You inherit ABO genetic information from your parents.

The ABO gene is located on chromosome 9.

Different versions of that gene help determine whether A antigen, B antigen, both, or neither is expressed in the familiar ABO pattern.

That means the letters printed beside your blood type are connected directly to your ancestry.

Parents pass blood group alleles to their children.

Those children pass genetic information to another generation.

This made blood groups useful for much more than transfusion medicine.

Before modern DNA testing, blood groups were used in population research, anthropology, genetics and some questions of biological parentage.

Today DNA gives us far more information, but blood groups remain one of the classic examples of inherited human variation.

Explore the genetics and history of the ABO blood group system

Landsteiner Wasn't Finished

What makes Landsteiner's story especially interesting to us is that discovering ABO wasn't the end of his research into human blood.

He continued studying antibodies, antigens and differences between individuals.

After leaving Europe, Landsteiner eventually joined the Rockefeller Institute for Medical Research in New York, known today as Rockefeller University.

His later research contributed to the discovery of additional blood group systems.

Working with Philip Levine, Landsteiner helped identify the M and N blood group factors in the 1920s.

And then came the discovery that would make his name especially important to the Rh negative community.

The Rh factor.

From ABO to Rh

Decades after Landsteiner's original ABO discovery, another mystery remained.

Even when doctors understood ABO compatibility, unexplained blood reactions could still occur.

Pregnancy presented another mystery.

Some women experienced pregnancies in which a baby developed severe anemia, jaundice or a dangerous condition historically known as erythroblastosis fetalis.

ABO alone could not explain everything.

In 1940, Landsteiner and Alexander Wiener reported experiments involving an antibody produced after animals were exposed to red blood cells from rhesus monkeys.

Their work became part of the scientific path toward what became known as the Rh blood group system.

The historical story is more complicated than simply saying one experiment discovered the modern human RhD antigen overnight. Other researchers and clinical observations were crucial to connecting human antibodies, pregnancy and what we now understand as Rh incompatibility.

But Landsteiner was once again standing near the center of a discovery that transformed medicine.

For the Rh negative community, that connection is remarkable.

The scientist who helped reveal the ABO blood groups at the beginning of the century was still investigating blood decades later when science began uncovering the system behind the positive and negative signs we recognize today.

Read more about Karl Landsteiner's life and later blood group research from the Nobel Prize

Why Rh Matters

The Rh blood group system is separate from ABO.

When someone says they are A negative, O negative or AB positive, those descriptions are combining information from more than one blood group system.

The letter describes ABO.

The positive or negative usually refers to whether the D antigen of the Rh system is detected.

That distinction becomes extremely important in transfusion medicine.

It can also become important during pregnancy when an RhD negative mother carries an RhD positive baby.

Today medicine can usually prevent RhD sensitization using Rh immune globulin in appropriate patients.

That entire field grew from generations of research into something doctors once couldn't even see.

A tiny antigen on the surface of a red blood cell could influence transfusion compatibility, pregnancy and the health of a newborn baby.

For a deeper look at what Rh negative actually means, read our True Blood Group research article:

What Is Rh Negative Blood? Separating Fact From Myth

And for the genetics underneath the simple positive and negative labels:

The Three Faces of RhD: Full RHD Deletion, Weak D and Partial D

The Nobel Prize

Landsteiner's work eventually received one of science's highest honors.

In 1930, Karl Landsteiner received the Nobel Prize in Physiology or Medicine “for his discovery of human blood groups.”

Think about the significance of that discovery.

Before blood groups were understood, transfusion could be a frightening experiment.

After scientists understood compatibility, blood could increasingly become something collected, tested, stored, matched and given systematically to another human being.

The discovery did not create modern blood banking by itself.

Many scientists, physicians, nurses, donors and institutions built the systems that followed.

But Landsteiner provided one of the essential pieces that made those systems possible.

Nobel Prize: Karl Landsteiner and the discovery of human blood groups

He Never Really Stopped

There is something about Landsteiner's life that I find particularly fitting.

He kept researching.

ABO could have defined his entire career.

It earned him a Nobel Prize.

Instead, he continued investigating immunity, antibodies and blood.

Landsteiner was working at the Rockefeller Institute well into old age.

In June 1943, while still working at the institute, he suffered a heart attack.

He died shortly afterward at the age of 75.

The man who spent much of his life studying human blood remained connected to his laboratory almost until the end.

Think About What Came From Those Experiments

A scientist mixes blood samples in Vienna.

He notices that some combinations clump while others don't.

From that observation grows an entirely new understanding of human blood.

Today, someone can be injured in a car accident and receive compatible blood in an emergency room.

A patient can undergo major surgery while donated blood is available if needed.

Cancer patients can receive blood products during treatment.

Premature babies can receive carefully selected blood.

Pregnant women can be screened for antibodies that could affect their babies.

Blood banks can search for rare donors when a patient has an uncommon blood type or antibody profile.

And ordinary people can walk into a blood center, donate part of themselves and potentially help save the life of a complete stranger.

Landsteiner could not have known exactly what the next century would build from his work.

But he helped provide the language that made all of it possible.

A.

B.

AB.

O.

And Then There Is Rh Negative Blood

For our community, Landsteiner's story has another layer.

Most people learn his name because of ABO.

We remember him for that too.

But his scientific journey eventually crossed directly into the history of Rh blood.

That means understanding Landsteiner isn't simply learning trivia about who discovered blood types.

It is understanding where modern blood science began.

ABO opened one door.

Rh opened another.

Genetics opened another.

Today scientists can sequence RHD genes and distinguish variants that earlier generations of researchers could never have identified.

Weak D.

Partial D.

Complete RHD deletion.

Rare blood group combinations.

Hundreds of blood group antigens across many systems.

What began with visible clumping in a laboratory has become molecular genetics.

And we are still learning.

Your Blood Can Save Someone Else

There is another part of Landsteiner's legacy that matters beyond history.

Blood cannot simply be manufactured on demand as a complete replacement for donated human blood.

Hospitals still depend on donors.

And rare blood types can become particularly important when a patient needs repeated transfusions or develops antibodies that make finding compatible blood more difficult.

Rh negative donors play an especially important role because Rh negative red blood cells are less common in the population.

O negative red blood cells are particularly important in emergencies because they can be used when there isn't enough time to determine a patient's blood type, although transfusion compatibility is more complicated than simply calling one type “universal.”

If you've ever wondered whether your blood could help someone, you can learn more through our blood donation resources.

True Blood Group Blood Donation Information

More Than a Letter Beside Your Name

Landsteiner's discovery reminds us why blood groups deserve serious study.

Your blood type is not simply a letter and a plus or minus symbol.

It reflects inherited biology.

It influences transfusion compatibility.

It can matter during pregnancy.

It connects to immunology.

It connects to genetics.

And across populations, blood group variation has even provided researchers with clues about human inheritance and population history.

More than a century after Landsteiner's first experiments, scientists are still studying what our blood can tell us.

That's one of the reasons True Blood Group exists.

We can explore the documented science.

We can explore the history.

We can investigate unanswered questions.

And when we move into theories or speculation, we can distinguish those ideas from what the evidence actually establishes.

Karl Landsteiner asked a deceptively simple question.

Why does one person's blood react differently from another person's blood?

The answer helped change medicine forever.

And we're still following where that question leads.

Question. Research. Verify & Discover.

Sources and Further Reading

Karl Landsteiner: Nobel Prize Facts

Karl Landsteiner: Nobel Prize Biography

National Library of Medicine: The ABO Blood Group

National Library of Medicine: A Brief History of Human Blood Groups

PubMed: Karl Landsteiner Discovers the Blood Groups

National Library of Medicine: Historical Overview of the Genetics of the ABO Blood Group System

National Library of Medicine: Karl Landsteiner, A Versatile Blood Scientist

Related True Blood Group Research

What Is Rh Negative Blood? Separating Fact From Myth

The Three Faces of RhD: Full RHD Deletion, Weak D and Partial D

Blood Donation and Donor Information